PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Erlotinib effective and with fewer side-effects after first-line treatment

European Multidisciplinary Conference in Thoracic Oncology news

2011-02-28
(Press-News.org) The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.

Dr Tudor Ciuleanu from the Institute of Oncology Ion Chiricuta, Cluj-Napoca, Romania, reported this finding from the international TITAN study at the European Multidisciplinary Conference in Thoracic Oncology (EMCTO), 24-26 February 2011, Lugano, Switzerland.

"The TITAN study is the first trial to evaluate whether erlotinib has comparable efficacy to chemotherapy for non-small cell lung cancer patients in general," Dr Ciuleanu said. The study included only patients whose disease had progressed under first-line chemotherapy. In the clinic, around 30-40% of patients with lung cancer will see no benefit from first-line therapy and their disease will rapidly progress.

"These patients have an extremely poor prognosis and few treatment options. An effective alternative to chemotherapy is therefore very important, since chemo-related side-effects can result in further physical deterioration in patients who are already very sick," Dr Ciuleanu said.

Historically, data have shown that erlotinib was more tolerable than chemotherapy, but many physicians had assumed that erlotinib would not be as effective in this difficult-to-treat patient population compared to chemotherapy.

The open-label study included 424 patients whose lung cancer had progressed rapidly after treatment with first-line chemotherapy. Of these, 203 were treated with erlotinib, and 221 received chemotherapy with either docetaxel or pemetrexed. No difference in overall survival was seen between the two groups, the researchers reported. Nor was there any significant difference in progression-free survival time.

"TITAN is important because it confirms that erlotinib has comparable efficacy to chemotherapy with better tolerability, even in this population of patients with poor prognosis," Dr Ciuleanu said. "The study included a broad, unselected population, showing that patients can benefit from erlotinib regardless of their EGFR mutation status. Erlotinib therefore gives doctors an effective alternative to chemotherapy after disease progression, without chemo-related side-effects."

Serious treatment-related adverse events were seen in only 1% of patients treated with erlotinib, the researchers said, compared to 6.6% of those in the chemotherapy arm of the study.

"The likelihood of side-effects is a serious consideration for patients who are already physically unwell due to the advanced stage of their disease," Dr Ciuleanu said. "The importance of this finding is that when safety data are considered they show that the benefits associated with erlotinib can be achieved with better tolerability than chemotherapy."

Commenting on the study, which he was not involved in, Professor Jean-Paul Sculier from Institut Jules Bordet, Belgium, noted that there are currently three drugs specifically registered for second-line single-agent treatment in advanced non-small cell lung cancer, all of which have the same impact on survival: erlotinib, pemetrexed (restricted to non-squamous histologies) and docetaxel.

"Docetaxel is no longer protected by patent, meaning it is cheaper and generics are available," he noted. "A potential advantage of erlotinib is administration in a targeted way for tumors with activating EGFR mutations, however more data are needed before the drug can be recommended with a good level of evidence in that indication."

### END


ELSE PRESS RELEASES FROM THIS DATE:

Canada's role grows amid looming world water shortages in some places, more flooding in others

Canadas role grows amid looming world water shortages in some places, more flooding in others
2011-02-28
Famed especially for the excellence of its peacekeepers and ice hockey players, Canada's water experts are now increasingly needed to help countries elsewhere brace for drought, flood and unsafe water problems looming on a 15 to 20 year horizon. Within a single generation, recent studies show, water demand in many countries will exceed supply by an estimated 40%, with one-third of humanity having half the water required for life's basics. In flood-prone places, meanwhile, catastrophic flood events normally expected once a century - similar to those recently witnessed ...

Advanced degrees add up to lower blood pressure

2011-02-28
PROVIDENCE, R.I. [Brown University] — Freshmen on the eve of finals and graduate students staring down a thesis committee may not feel this way, but the privilege of obtaining an advanced education correlates with decades of lower blood pressure, according to a study led by a public health researcher at Brown University. The benefit appears to be greater for women than for men. Eric Loucks, assistant professor of community health, says the analysis of nearly 4,000 patient records from the 30-year Framingham Offspring Study may help explain a widely documented association ...

Immune molecule regulates brain connections

2011-02-28
The number of connections between nerve cells in the brain can be regulated by an immune system molecule, according to a new study from UC Davis. The research, published Feb. 27 in the journal Nature Neuroscience, reveals a potential link between immunity, infectious disease and conditions such as schizophrenia or autism. Schizophrenia, autism and other disorders are associated with changes in connectivity in the brain, said Kimberley McAllister, associate professor in the Center for Neuroscience and Departments of Neurology and Neurobiology, Physiology and Behavior ...

First aid for the under 5s

2011-02-28
One of the reasons often given by people for not attempting first aid in emergency situations is a lack of confidence and a fear of doing more harm than good. Yet a Norwegian study on four and five year olds published in BioMed Central's open access journal Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine shows that even young children are able to learn and perform basic first aid. Pre-school children at a kindergarten in Bergen, Norway, were taught first aid using the 'five-finger-rule' system: look at the person, talk to them, touch them to try ...

How education can save your life

2011-02-28
It is known that education decreases the incidence of cardiovascular disease. New research published in BioMed Central's open access journal BMC Public Health demonstrates that education is also correlated with lower blood pressure and a decrease in other factors which influence health such as alcohol, smoking and weight gain. Taking their data from The Framingham Offspring Study researchers followed 3890 people, for 30 years, monitoring their medical history, how long they stayed in education, and their levels of coronary heart disease. Educated men (greater than 17 ...

Canadian researchers first worldwide to generate pluripotent stem cells from horses

2011-02-28
In a world first, pluripotent stem cells have been generated from horses by a team of researchers led by Dr. Andras Nagy at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Lawrence Smith at the University of Montreal's Faculty of Veterinary Science. The findings will help enable new stem-cell based regenerative therapies in veterinary medicine, and because horses' muscle and tendon systems are similar to our own, aid the development of preclinical models leading to human applications. The study was published in the February 28 issue of the leading ...

Fish oil fights weight loss due to chemotherapy

2011-02-28
A new analysis has found that supplementing the diet with fish oil may prevent muscle and weight loss that commonly occurs in cancer patients who undergo chemotherapy. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that fish oil may help combat cancer-related malnutrition. Chemotherapy can cause cancer patients to lose muscle mass and become malnourished, leading to fatigue, a decreased quality of life, an inability to receive necessary treatments, and shorter survival. Researchers suspect that supplementing ...

Gene fuelled transporter causes breast cancer cells to self-destruct

2011-02-28
Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today (28 February) in the International Journal of Pharmaceutics. Using a transport system called a Designer Biomimetic Vector (DBV), Dr Helen McCarthy, from Queen's School of Pharmacy, funded by Breast Cancer Campaign, packaged a gene into a nanoparticle 400 times smaller than the width of a human hair, allowing it to be delivered straight ...

Hearing loss rate in older adults climbs to more than 60 percent in national survey

2011-02-28
Nearly two-thirds of Americans age 70 and older have hearing loss, but those who are of black race seem to have a protective effect against this loss, according to a new study led by Johns Hopkins and National Institute on Aging researchers. These findings, published online Feb. 28 in the Journal of Gerontology: Medical Sciences, provide what is believed to be the first nationally representative survey in older adults on this often ignored and underreported condition. Contrary to the view that hearing loss is of only minor importance in old age, study leader Frank Lin, ...

University of Miami scientists track great hammerhead shark migration

University of Miami scientists track great hammerhead shark migration
2011-02-28
MIAMI – Feb 28, 2011 – A study led by scientists at the University of Miami (UM) Rosenstiel School of Marine & Atmospheric Science details the first scientific research to successfully track a great hammerhead shark using satellite tag technology. Rosenstiel Schhol Research Assistant Professor Neil Hammershlag and colleagues tracked one of the nomadic sharks for 62 days to uncover its northeast journey from the coast of South Florida to the middle of the Atlantic off the coast of New Jersey. The straight line point-to-point distance of 1,200 kilometers (745 miles) represents ...

LAST 30 PRESS RELEASES:

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

[Press-News.org] Erlotinib effective and with fewer side-effects after first-line treatment
European Multidisciplinary Conference in Thoracic Oncology news